Distinct Roles for the XPB/p52 and XPD/p44 Subcomplexes of TFIIH in Damaged DNA Opening during...
-
Upload
independent -
Category
Documents
-
view
3 -
download
0
Transcript of Distinct Roles for the XPB/p52 and XPD/p44 Subcomplexes of TFIIH in Damaged DNA Opening during...
Molecular Cell
Article
Distinct Roles for the XPB/p52 and XPD/p44Subcomplexes of TFIIH in Damaged DNAOpening during Nucleotide Excision RepairFrederic Coin,1,* Valentyn Oksenych,1 and Jean-Marc Egly1,*1 Institut de Genetique et de Biologie Moleculaire et Cellulaire, CNRS (UMR7104)/INSERM (U596)/ULP, BP 163,
67404 Illkirch Cedex, C.U. Strasbourg, France
*Correspondence: [email protected] (F.C.), [email protected] (J.-M.E.)DOI 10.1016/j.molcel.2007.03.009
SUMMARY
Mutations in XPB, an essential subunit of thetranscription/repair factor TFIIH, lead to nucleo-tide excision repair (NER) defects and xero-derma pigmentosum (XP). The role of XPB inNER and the molecular mechanisms resultingin XP are poorly understood. Here, we show thatthe p52 subunit of TFIIH interacts with XPB andstimulates its ATPase activity. A mutation foundamong XP-B patients (F99S) weakens this inter-action and the resulting ATPase stimulation,thereby explaining the defect in the damagedDNA opening. We next found that mutations inthe helicase motifs III (T469A) and VI (Q638A)that inhibit XPB helicase activity preserve theNER function of TFIIH. Our results suggesta mechanism in which the helicase activity ofXPB is not used for the opening and repair ofdamaged DNA, which is instead only drivenby its ATPase activity, in combination with thehelicase activity of XPD.
INTRODUCTION
The human transcription/repair factor IIH (TFIIH) consists
of ten subunits. XPB, XPD, p62, p52, p44, p34, and p8/
TTDA form the core complex, while cdk7, MAT1, and cy-
clin H form the cdk-activating kinase (CAK) subcomplex,
linked to the core via XPD. Hereditary mutations in either
XPB, XPD, or p8/TTDA yield the xeroderma pigmentosum
(XP), XP combined with Cockayne syndrome (XP/CS), or
trichothiodystrophy (TTD) syndromes (Lehmann, 2003;
Giglia-Mari et al., 2004; Oh et al., 2006). These diseases
exhibit a broad spectrum of clinical features including
photosensitivity of the skin due to defects in nucleotide
excision repair (NER) (Lehmann, 2003). NER is part of a
cellular defense system that protects genome integrity
by removing a wide diversity of helix-distorting DNA le-
sions induced by ultraviolet (UV) light and bulky chemical
adducts. The removal of lesions requires their recognition
Mo
by the repair factor XPC-HR23b and the subsequent un-
winding of the DNA duplex by TFIIH. The single-stranded
structure is then stabilized by XPA and RPA, and the mar-
gins of the resulting DNA bubble are recognized by XPG
and ERCC1-XPF, thereby generating 30 and 50 incisions
relative to the damage (O’Donnovan et al., 1994; Sijbers
et al., 1996).
DNA helicases are motor proteins that can transiently
catalyze the unwinding of the stable duplex DNA mole-
cules using NTP hydrolysis as the source of energy. They
are characterized by seven ‘‘helicase motifs,’’ constituted
of conserved amino acid sequences (Tuteja and Tuteja,
2004). It was always hypothesized that XPB and XPD
helicase subunits of TFIIH supply opposite unwinding ca-
pacities required for local helix opening to form the open
DNA intermediates in NER (Bootsma and Hoeijmakers,
1993). Indeed, mutations in the ATP binding site of these
proteins inhibit NER in vivo and in vitro (Guzder et al.,
1994; Sung et al., 1988), due to a defect in the opening
of the damaged DNA structure (Coin et al., 2006). How-
ever, these studies used mutants that act by targeting
the ATPase A Walker I motif, but not the other helicase
motifs (from II to VI). Thus, questions remain as to whether
DNA opening during repair requires both XPB and XPD
helicases to open a short sequence of 24/32 nucleotides
encompassing the lesion.
Thus far, investigations of the mechanistic defects lead-
ing to XP, CS, or TTD have been beneficial in understand-
ing the function of XPB, XPD, and p8/TTDA in NER and
in transcription (Evans et al., 1997; Keriel et al., 2002;
Dubaele et al., 2003, Coin et al., 2006). In this study, we
unveiled the role of both the XPB and XPD subunits of
TFIIH in NER by analyzing several mutations found in XP
patients or other engineered mutations introduced in
highly conserved domains of the corresponding proteins.
We found that the helicase activity of XPB was not used for
damaged DNA opening, which is instead driven by its
ATPase activity, in combination with the helicase activity
of XPD. Furthermore, we demonstrated that the p52 sub-
unit of TFIIH upregulates the ATPase activity of XPB
through a direct XPB/p52 contact that is impaired in
XP-B patients. The TFIIH from these patient is unable to
induce the opening of the DNA around the lesion, due to
the incorrect XPB/p52 interaction and ATPase stimulation.
lecular Cell 26, 245–256, April 27, 2007 ª2007 Elsevier Inc. 245
Molecular Cell
Role of XPB and XPD in DNA Repair
RESULTS
The F99S Mutation in XPB Impairs Damaged
DNA Opening
To provide insights into the role of XPB in NER, we investi-
gated the DNA repair activity of two TFIIH complexes
purified from cell extracts of XP-B patients carrying either
the F99S (XP) or the T119P (TTD) mutations (Oh et al.,
2006) (Figure 1A, left panel). Western blot analysis reveals
a similar subunit composition of the immunopurified TFIIH/
XPB(WT), TFIIH/XPB(F99S), and TFIIH/XPB(T119P) com-
plexes (Figure 1A, right panel). Upon addition of TFIIH/
XPB(F99S) to a reconstituted in vitro dual incision assay
(Coin et al., 2004), a low level (10% activity) of excised
damaged oligonucleotides was observed, compared
with TFIIH/XPB(WT) (Figure 1B, NER, compare lanes 5
and 6 with lanes 3 and 4). TFIIH/XPB(F99S) was more effi-
cient in a reconstituted transcription assay (Gerard et al.,
1991) (75% activity) than in dual incision (Tx, compare
lanes 5 and 6 with lanes 3 and 4). The T119P mutation
did not affect either dual incision or transcription activities
(compare lanes 7 and 8 with lanes 3 and 4).
Given the role of TFIIH in NER, we carried out a perman-
ganate footprinting assay measuring the opening of the
DNA around the damage (Evans et al., 1997). Addition of
either TFIIH/XPB(WT) or TFIIH/XPB(T119P) to a reaction
containing XPC-HR23b, in addition to the cisplatinated
DNA fragment, resulted in an increased sensitivity of nu-
cleotides at positions T-4, T-5, and, to a lesser extent,
T-7 and T-10 indicative of DNA opening (Figure 1C, com-
pare lane 2 with lanes 5 and 9). In contrast, addition of
TFIIH/XPB(F99S) did not trigger a detectable opening of
the damaged DNA (Figure 1C, lane 7). However, further
addition of the NER factor XPA to TFIIH/XPB(F99S) pro-
moted a weak but significant opening of the DNA, com-
pared with the full opening obtained with either TFIIH/
XPB(WT) or (T119P) (Figure 1C, compare lane 8 to lanes
6 and 10). This defect in DNA opening parallels and ex-
plains the low removal of damaged oligonucleotides
seen in Figure 1B.
To dissect the molecular mechanism of the NER defect
observed with the F99S mutation, we purified from bacu-
lovirus-infected insect cells a recombinant TFIIH complex
(IIH6) containing the six subunits of the core TFIIH (XPB,
XPD, p62, p52, p44, and p34). The following experiments
were performed only with the core TFIIH, since the CAK
complex did not play any role in our in vitro NER assay
(Coin et al., 2006). Similarly to the endogenous TFIIH/
XPB(F99S), the recombinant IIH6/XPB(F99S) showed a
lower repair activity, compared with either IIH6/XPB(WT)
or (T119P) (Figure 1D, compare lane 5 with lanes 1 and
7). Interestingly, the addition of the NER-specific TFIIH
subunit p8/TTDA to IIH6/XPB(F99S) did not stimulate inci-
sion, compared with the increase in the removal of dam-
aged oligonucleotides observed with either the IIH6/
XPB(WT) or IIH6/XPB(T119P) complexes (Figure 1D,
compare lane 6 with lanes 2 and 8). Next, we observed
that addition of p8/TTDA and XPA to IIH6/XPB(F99S) did
246 Molecular Cell 26, 245–256, April 27, 2007 ª2007 Elsevier In
not trigger optimal opening of the damaged DNA in a per-
manganate footprinting assay, compared with either IIH6/
XPB(WT) or IIH6/XPB(T119P) (Figure 1E, compare lanes
10–12 with lanes 4–6 and 13–15). As a control, mutation
in the XPB ATPase A Walker I motif totally abolished the
IIH6/XPB(K346R) repair activity (Figure 1D, lane 3), due
to an inhibition of the damaged DNA opening (Figure 1E,
lane 7) and regardless of the presence of p8/TTDA (Fig-
ure 1D, lane 4, and Figure 1E, lanes 8 and 9).
Finally, the recruitment of both TFIIH and XPA to the
lesion was tested in vivo following local UV irradiation of
wild-type MRC5 and XPCS2BA (bearing the F99S muta-
tion) nuclei (Volker et al., 2001). Fluorescence signals of
XPB colocalized with cyclobutane pyrimidine dimer (CPD)
spots both in wild-type MRC5 and XPCS2BA cells (Fig-
ures 2A–2D), indicating that TFIIH/XPB(F99S) translocates
to the sites of DNA photolesions. In contrast, XPA was not
recruited to the lesions in XPCS2BA, compared to MRC5
cells (Figures 2E–2H). At this point, we concluded that the
repair defect harbored by TFIIH/XPB(F99S) is at the open-
ing step, following the binding of TFIIH to the damaged
DNA.
p52 Stimulates the ATPase Activity of XPB
Having observed that the F99S mutation does not impair
the helicase activity of the recombinant XPB protein (data
not shown), we focused on the ATPase activity of XPB. We
observed that the core IIH6/XPB(F99S) complex displayed
a lower ATPase activity (30% activity) than those of IIH6/
XPB(WT) and IIH6/XPB(T119P) (Figure 3A). Enigmatically,
the free XPB(F99S) polypeptide exhibited a catalytic
ATPase activity similar to those of XPB(WT) or XPB(T119P)
(Figure 3B). These observations prompted us to examine
if XPB-interacting subunits in TFIIH could modulate its
ATPase activity. Addition of increasing amounts of p52, a
partner of XPB in TFIIH (Jawhari et al., 2002), to a fixed
amount of purified XPB significantly stimulated its ATPase
activity (Figure 3C, lanes 2–4). To the contrary, addition of
either p44 or p8/TTDA, two subunits of TFIIH that do not
interact with XPB, had no effect on the ATPase (Figure 3C,
lanes 5, 6, 8, and 9).
We next investigated if XPB(F99S) and XPB(T119P) were
detrimental for the XPB/p52 interaction. Equal amounts
of recombinant XPB(WT), XPB(F99S), and XPB(T119P),
immobilized on agarose beads, were incubated with p52-
expressing extracts. Following extensive washing, we
observed in our experimental conditions that XPB(F99S)
interacts much less with p52 than do XPB(WT) or
XPB(T119P) (Figure 3D, compare lanes 8 and 9 and 5
and 6 with lanes 2 and 3). When tested in an ATPase
assay, p52 weakly stimulated XPB(F99S), compared with
XPB(WT) (Figure 3E, compare lanes 5–7 with lanes 2–4).
Altogether, these results demonstrate first that p52 regu-
lates XPB ATPase activity and second that a mutation
found in XP-B/CS patients weakens the interaction be-
tween the regulatory subunit p52 and XPB, leading to a
low stimulation of the ATPase activity and a reduced open-
ing of DNA around the damage.
c.
Molecular Cell
Role of XPB and XPD in DNA Repair
Figure 1. The F99S Mutation Impairs Damaged DNA Opening
(A) (Left) Schematic representation of XPB. The dark gray boxes indicate the helicase domains. The light gray box indicates the conserved N-terminal
domain. Mutations found in XP-B patients (F99S and T119P) and mutation in the ATPase A Walker I motif (K346R) are depicted. (Right) Two estab-
lished clones derived from the XPCS2BA cell line (mutation F99S) and expressing either the F99S (XP) or T119P (TTD) XPB (Riou et al., 1999) were
used together with the MRC5 control cell line for TFIIH purification. TFIIH/XPB(WT), TFIIH/XPB(F99S), and TFIIH/XPB(T119P) were immunoprecipi-
tated with antibody toward p44, a subunit of the core TFIIH, from whole-cell extracts and eluted with a competitor peptide (Coin et al., 1999). The
samples were resolved by SDS-PAGE and western blotted (WB) with anti-TFIIH antibodies. The subunits of TFIIH are indicated.
(B) Fifty and one hundred nanograms of TFIIH/XPB(WT) (lanes 3 and 4), TFIIH/XPB(F99S) (lanes 5 and 6), or TFIIH/XPB(T119P) (lanes 7 and 8) were
tested in a dual incision assay (NER) containing the recombinant XPC-HR23b, XPA, RPA, XPG, ERCC1-XPF factors and a closed-circular plasmid
containing a single 1,3-intrastrand d(GpTpG) cisplatin-DNA crosslink (Pt-DNA) as a template (Frit et al., 2002) or in a reconstituted transcription assay
(Tx) composed of recombinant TFIIB, TFIIF, TBP, TFIIE factors, the purified RNA polymerase II, and the adenovirus major late promoter template
(Gerard et al., 1991). Sizes of the incision products or transcripts are indicated.
(C) TFIIH (100 ng) was incubated with a radiolabeled linear DNA fragment from the Pt-DNA plasmid and 40 ng of XPC-HR32b. XPA (25 ng) was added
when indicated. Lane 1, Pt-DNA with BSA only. Residues are numbered with the central thymine of the crosslinked GTG sequence designated T0.
Arrows indicate KMnO4-sensitive sites. Adducted strand residues to the 30 and 50 ends of T0 are denoted by positive and negative integers (+N,�N).
(D) The recombinant IIH6/XPB(WT), IIH6/XPB(K346R) (mutated in the ATPase A Walker I site), IIH6/XPB(F99S), and IIH6/XPB(T119P) lacking CAK and
p8/TTDA were produced in baculovirus-infected insect cells (Tirode et al., 1999). TFIIH (100 ng) was tested in dual incision in the presence of 3 ng of
recombinant p8/TTDA when indicated (lanes 2, 4, 6, and 8).
(E) A KMnO4 assay was performed as described in Figure 1C with 100 ng of recombinant IIH6 complex incubated with a radiolabeled linear DNA
fragment from the Pt-DNA plasmid and XPC-HR32b. XPA (25 ng) and p8/TTDA (6 ng) were added when indicated. Lane 1, Pt-DNA with BSA only.
Lane 2, positive control with TFIIH purified from HeLa.
Molecular Cell 26, 245–256, April 27, 2007 ª2007 Elsevier Inc. 247
Molecular Cell
Role of XPB and XPD in DNA Repair
Figure 2. Recruitment of TFIIH and XPA at Sites of UV Damage
XPCS2BA(F99S) and wild-type MRC5 (labeled with blue beads) cells were plated on the same slide. Cells were UV irradiated with 70 J/m2 through a 3
mm pore filter and fixed 30 min later. Immunofluorescent labeling was performed using a rabbit polyclonal anti-XPB (A), a mouse monoclonal anti-CPD
(B and F) or a rabbit polyclonal anti-XPA (E). Nuclei were counterstained with DAPI (C and G), and slides were merged (D and H).
To map the region of p52 that is involved in the stimula-
tion of XPB ATPase activity, we designed the p52(1–304)
and the p52(305–462) truncated polypeptides (Figure 4A),
knowing that p52 interacts with XPB through two distinct
domains comprising the residues 1–135 and 304–381 (Ja-
whari et al., 2002). Equal amounts of purified recombinant
p52(WT), p52(1–304), and p52(305–462) were incubated
with fixed amount of purified recombinant XPB(WT) in an
ATPase assay. Both p52(WT) and p52(305–462) stimu-
lated XPB ATPase activity (Figure 4B, lanes 3–5 and 9–11,
respectively), while addition of p52(1–305) did not show
any significant effect (lanes 6–8). We also noticed that
p52(1–358), a truncated p52 polypeptide mimicking a
mutation found in yeast (Jawhari et al., 2002), efficiently
stimulated the XPB ATPase (data not shown and Jawhari
et al. [2002]). Altogether, our data indicate that the XPB
ATPase stimulation depends on the second XPB-interact-
ing domain in p52, delimited by residues 305 and 358.
Mutations in Helicase Domains of XPB Preserve
TFIIH Repair Activity
We next explored the combined action, if any, of both the
ATPase and helicase activities of XPB in NER. Since the
helicase activity of XPB depends on the integrity of seven
conserved motifs (Weeda et al., 1990), we designed two
recombinant XPB proteins. The first T469A mutation is
located in the helicase motif III, which is involved in the
unwinding of the DNA. Such mutation in the domain III
has been reported to impair the helicase activity of several
SF2 helicase family members (Pause and Sonenberg,
1992; Papanikou et al., 2004), including XPB (Lin et al.,
2005). The second Q638A mutation is located in the heli-
248 Molecular Cell 26, 245–256, April 27, 2007 ª2007 Elsevie
case motif VI, involved in the interaction with the single-
stranded DNA (Tuteja and Tuteja, 2004) (Figure 5A), and
was shown to be detrimental for XPB helicase activity
(Lin et al., 2005). We found that both recombinant
XPB(T469A) and (Q638A) displayed a very low 30–50 heli-
case activity, compared with XPB(WT) (Figure 5B, upper
panel, compare lanes 5 and 6 and 8 and 9 with lanes 2
and 3), while neither T469A nor Q638A mutations inter-
fered with XPB ATPase activity (Figure 5B, lower panel).
Remarkably, IIH6/XPB(T469A) and IIH6/XPB(Q638A) re-
moved damaged DNA as efficiently as did IIH6/XPB(WT)
in a dual incision assay (Figure 5C, compare lanes 7–9
and 10–12 with lanes 1–3), while their ability to allow RNA
synthesis was decreased when added to a reconstituted
transcription system (50% and 20% activity, respectively)
(Figure 5D, compare lanes 7–9 and 10–12 with lanes 1–3).
In contrast, IIH6/XPB(K346R), deficient in the ATPase
activity of XPB, was inactive both in DNA repair and tran-
scription (Figures 5C and 5D, lanes 4–6). In a permanga-
nate assay, addition of either TFIIH/XPB(WT) or TFIIH/
XPB(T469A) to a reaction containing XPC-HR23b and
p8/TTDA resulted in a DNA opening around the lesion, de-
pendent on the addition of ATP (Figure 5E, lanes 3–5 and
9–11). By contrast, a mutation in the ATPase A Walker
motif I (TFIIH/XPB[K346R]) inhibited the DNA-damaged
opening (lanes 6–8) (Coin et al., 2006).
To assess the importance of the helicase activity of XPB
during NER in vivo, a host cell reactivation assay was per-
formed (Carreau et al., 1995). A reporter construct (pLuc),
carrying a luciferase gene, was damaged by UV irradiation
and transfected in the repair-deficient CHO27-1 cells,
mutated in the XPB (Ma et al., 1994), together with an
r Inc.
Molecular Cell
Role of XPB and XPD in DNA Repair
undamaged control vector coding for b-galactosidase and
an expression vector coding for the human XPB proteins
of interest. Expression of the UV-irradiated reporter gene
was suppressed in CHO27-1, due to their repair defect (Fig-
ure 5F, compare lane 2 with lane 3). Cotransfection of
XPB(WT)cDNApartially restored luciferase gene expression
(lanes 3 and 4), while cotransfection of XPB(fs740) cDNA
containing a mutation that abolishes NER (Coin et al.,
2004) did not (Figure 5F, lane 6). The recovery of luciferase
activity is incomplete, probably due to species-specific
differences between human and hamster XPB. Cotrans-
fection of XPB(T469A) cDNA allowed an increase in the lu-
ciferase expression that reaches the level observed with
XPB(WT) (lanes 4 and 5), demonstrating that the T469A
mutation spares TFIIH repair activity in vivo. Altogether,
we show that, while the helicase activity of XPB is dispens-
able for effective NER, its ATPase activity is required.
Mutations Impairing XPD Helicase Activity Thwart
the Repair Activity of TFIIH
We next addressed if XPD, the other helicase of TFIIH,
might be contributing to the opening of the damaged DNA.
We designed recombinant IIH6 complexes with XPD con-
taining either the R658H, R683W, or R722W mutations
found within XP/TTD patients or the K48R mutation lo-
cated in the ATPase A Walker I motif (Figure 6A). As they
prevent the interaction of XPD with p44, the R683W and
R722W mutations impair the helicase activity of XPD,
while R658H conveys to its partial inhibition (Dubaele
et al., 2003). The K48R mutation inhibits both ATPase
and helicase activities of XPD (Tirode et al., 1999). Using
the permanganate footprinting assay, we showed that
damaged DNA opening was impeded in the absence of
the XPD ATPase activity (Figure 6B, lanes 5 and 6). Simi-
larly, R683W and R722W hindered damaged DNA open-
ing, even in the presence of p8/TTDA (Figure 6B, lanes
7, 8, 11, and 12). In contrast, R658H is sensitive to the
addition of p8/TTDA, and we observed a limited but signif-
icant opening of the DNA around the lesion with the corre-
sponding mutated complex (Figure 6B, lane 10). Interest-
ingly, the rate of dual incision activity obtained with the
IIH6/XPD(R658H) complex (50% activity) (Figure 6C,
compare lanes 6–8 with lanes 3–5) parallels the level of
DNA opening. Finally, the presence of the XPB(T469A)
subunit within IIH6/XPD(R658H) resulted in the IIH6/
XPD(R658H)/XPB(T469A) complex exhibiting a dual inci-
sion activity similar to that of IIH6/XPD(R658H), regardless
of the presence of p8/TTDA (Figure 6C, compare lanes 9–
11 with lanes 6–8). In conclusion, our results reveal that
DNA opening in NER depends on the ATPase, but not
on the helicase, activity of XPB in combination with the
helicase activity of XPD.
DISCUSSION
p52, a New Regulatory Subunit in TFIIH
By dissecting the repair defect induced by the F99S muta-
tion found in XP-B patients, we have shed light on the im-
Mol
portance of the partnership between XPB and p52 in NER.
We demonstrated that the F99S mutation in XPB weakens
the interaction with p52 and the resulting stimulation of its
ATPase activity, thereby inhibiting the opening of the dam-
aged DNA and the removal of the lesion. Given its role, p52
can be considered as a regulatory subunit of the ATPase
activity of XPB within TFIIH. Recently, it was shown that
p8/TTDA participates in the regulation of the ATPase ac-
tivity of XPB within the TFIIH complex, even though these
two subunits do not interact. However, p8/TTDA interacts
with p52 (Coin et al., 2006), and it is likely that the free p8/
TTDA, which was shown to shuttle between the cytoplasm
and nucleus and to associate with TFIIH when NER-spe-
cific DNA lesions are produced (Giglia-Mari et al., 2006),
would regulate or stabilize the XPB/p52 interaction within
the TFIIH complex. Thus, the binding of p8/TTDA to TFIIH
and the resulting stimulation of the XPB ATPase activity by
p52 might constitute a crucial NER checkpoint, deciding
whether or not a lesion will be removed. In the light of
the 3D structure of an archea XPB homolog (Fan et al.,
2006), it was proposed that ATP hydrolysis by XPB drives
a large conformational change inducing a reorientation
of a moiety of XPB and its wrapping around the DNA.
Accordingly, it is likely that p52 together with p8/TTDA
regulates this conformational change through the stimula-
tion of the ATPase activity of XPB.
Is XPB a Conventional Helicase in NER?
The removal of lesions depends on the opening of the DNA
around the damaged site. Natural mutations in either the
XPB or the XPD proteins can disable DNA opening (Evans
et al., 1997). A remaining question is this: do both DNA
helicase activities function during the NER reaction? Mu-
tations in the ATP binding site of XPB and XPD totally
impede the formation of the open DNA structure in NER
(Sung et al., 1988; Guzder et al., 1994; Coin et al., 2006).
However, such observations indicate that the hydrolysis
of ATP by XPB is essential for the function of TFIIH in repair
but do not demonstrate that the helicase activity of XPB is
required for NER. It raises the possibility that the ATPase
activity is not only a provider of energy for the helicase
action but also displays another independent and distinct
function. This hypothesis is strengthened by the fact that
the stimulation of the ATP hydrolysis by the XPB/p52 part-
nership does not increase XPB helicase activity (data not
shown). Furthermore, TFIIH-bearing mutations in the heli-
case motifs III or VI of XPB are still functional in NER. This
supports the idea that XPB doesn’t act as a conventional
helicase in NER, a role that is devoted to XPD, the other
helicase of TFIIH. Indeed, we demonstrated that muta-
tions weakening the contact of XPD with its p44 regulatory
subunit (Coin et al., 1998; Dubaele et al., 2003) impair
damaged DNA opening. In this context, we favor a model
in which the wrapping of XPB around the DNA will allow for
a local melting of the double-stranded DNA around the
lesion that would favor the correct anchoring of the XPD
helicase. XPB would therefore play the role of a wedge,
using ATP to keep the two strands of the DNA around
ecular Cell 26, 245–256, April 27, 2007 ª2007 Elsevier Inc. 249
Molecular Cell
Role of XPB and XPD in DNA Repair
250 Molecular Cell 26, 245–256, April 27, 2007 ª2007 Elsevier Inc.
Molecular Cell
Role of XPB and XPD in DNA Repair
Figure 4. Mapping the Domain of p52
Involved in the Stimulation of the XPB
ATPase
(A) Schematic representation of p52. The
stretches of highly conserved residues in
eukaryotes are indicated in black, and XPB
binding regions are delimited.
(B) Purified FLAG-tagged p52(WT) (25, 50, and
100 ng) (lanes 3–5), p52(1–304) (lanes 6–8), and
p52(305–462) (lanes 9–11) were incubated with
50 ng of recombinant XPB (lanes 2–11) and
then resolved by SDS-PAGE and western
blotted against XPB and the FLAG tag (WB)
or incubated in an ATPase assay (ATPase).
the lesion apart, allowing XPD to unwind the DNA. This
model also brings together the modes of action of XPB
in the opening of the DNA around the promoter and
around the lesion (Lin et al., 2005).
Molec
TFIIH Repair Disorders, a Matter of Interactions
So far in humans, viable TFIIH mutations have been found
only in XPB, XPD, and p8/TTDA. Our work reveals that mu-
tations found in XP-B and -D patients never affect the
Figure 3. The F99S Mutation Thwarts the Interaction between XPB and p52 and the Stimulation of XPB ATPase Activity
(A) Increasing amounts (50, 100, 200, and 400 ng) of either IIH6/XPB(WT), IIH6/XPB(F99S), or IIH6/XPB(T119P) were tested in an ATPase assay. The
graph represents the percentage of phosphate released (Pi/[ATP+Pi]) from three independent experiments.
(B) Increasing amounts (20, 40, 80, and 160 ng) of either XPB(WT), XPB(F99S), or XPB(T119P) were tested in an ATPase assay. The graph represents
the percentage of phosphate released (Pi/[ATP+Pi]) from three independent experiments.
(C) Purified XPB (50 ng) (lanes 2–9) was tested in an ATPase assay in the presence of 50 and 100 ng of purified p52 (lanes 3 and 4), 10 and 20 ng of
purified p8/TTDA (lanes 5 and 6), or 50 and 100 ng (lanes 8 and 9) of purified p44 subunits of TFIIH.
(D) XPB(WT) (lanes 1–3), XPB(F99S) (lanes 4–6), or XPB(T119P) (lanes 7–9) from baculovirus-infected insect cell extracts were immunoprecipitated
with anti-XPB antibody. Following washes, beads were incubated with baculovirus-infected insect cell extracts expressing p52, washed at 0.2 or
0.4 M KCl as indicated, and then resolved by SDS-PAGE and western blotted. HC, Ab heavy chain.
(E) XPB(WT) (lanes 2–4) or XPB(F99S) (lanes 5–7) from baculovirus-infected insect cell extracts were immunoprecipitated with anti-XPB antibody.
Following washes, beads were incubated with increasing amounts of baculovirus-infected insect cell extracts expressing p52, washed at 0.4 M
KCl, and then tested in an ATPase assay or resolved by SDS-PAGE and western blotted as indicated. HC, Ab heavy chain.
ular Cell 26, 245–256, April 27, 2007 ª2007 Elsevier Inc. 251
Molecular Cell
Role of XPB and XPD in DNA Repair
Figure 5. Mutations in Helicase Domains of XPB Spare TFIIH Repair Activity
(A) Schematic representation of XPB. Mutations introduced in conserved helicase domains are indicated.
(B) (Upper panel) Immunoprecipitated recombinant XPB (50 and 200 ng) (expressed in baculovirus-infected insect cells) were tested in helicase assay
using a bidirectional probe (Coin et al., 1998) at either 37�C or 4�C as indicated. Lane 1 contains highly purified TFIIH from HeLa cells. D, probe has
been heated 5 min at 100�C. Lane 11 is a control without XPB. Values under the autoradiograph represent the percentage of probe (30/50 ) released
relative to control lane 12. (Lower panel) Immunoprecipitated XPB (50 and 200 ng) was tested in an ATPase assay at 30�C or 4�C when indicated.
Values under the autoradiograph represent the percentage of phosphate released (Pi/[ATP+Pi]).
(C) One hundred nanograms of either IIH6/XPB(WT) (lanes 1–3), IIH6/XPB(K346R) (lanes 4–6), IIH6/XPB(T469A) (lanes 7–9), or IIH6/XPB(Q638A) (lanes
10–12) was tested in a dual incision assay in the presence of increasing amount of p8/TTDA (1.5 and 3 ng) as indicated.
(D) The TFIIH (50, 100, and 200 ng) tested in (C) was assessed in a reconstituted transcription assay as in Figure 1B, in the presence of 50 ng of
recombinant CAK complex (Rossignol et al., 1997). The size of the transcript is indicated.
(E) Fifty and one hundred nanograms of IIH6/XPB(WT) (50 and 100 ng) (lanes 3–5), IIH6/XPB(K346R) (lanes 6–8), or IIH6/XPB(T469A) (lanes 9–11) were
incubated with p8/TTDA and XPC-HR32b, with or without ATP, in a KMnO4 assay. Lane 1, Pt-DNA with BSA only. Lane 2, positive control with TFIIH
purified from HeLa.
(F) CHO27-1 cells were transfected with pLuc plasmid expressing the luciferase gene previously irradiated (lanes 3–6) or not (lane 2) in combination
with pcDNA expressing either XPB(WT) (lane 4), XPB(T469A) (lane 5), or XPB(fs740) (lane 6). Repair complementation was assessed by monitoring
252 Molecular Cell 26, 245–256, April 27, 2007 ª2007 Elsevier Inc.
Molecular Cell
Role of XPB and XPD in DNA Repair
Figure 6. The XPD Helicase Activity
Opens Damaged DNA in NER
(A) Schematic representation of XPD. The heli-
case domains are indicated by dark gray boxes.
The region of interaction with the regulatory
subunit p44 is highlighted (Coin et al., 1998;
Dubaele et al., 2003).
(B) A KMnO4 assay, as described in Figure 1C,
was performed with 100 ng of TFIIH incubated
with the Pt-DNA, XPC-HR32b, and XPA. Eight
nanograms of p8/TTDA was added when indi-
cated. Lane 1, Pt-DNA with BSA only.
(C) One hundred nanograms of IIH6/XPD(WT)
(lanes 3–5), IIH6/XPD(R658H) (lanes 6–8), or
IIH6/XPD(R658H)/XPB(T469A) (lanes 9–11)
was tested in a dual incision assay with increas-
ing amounts of p8/TTDA (1.5 and 3 ng). Values
under the autoradiograph represent the repair
activity (RA) calculated from three independent
experiments.
activity of the protein per se (helicase for XPD, ATPase for
XPB) but rather disturb the interactions of these enzymes
with their regulatory partners (p44 for XPD and p52 for
XPB), explaining how patients with such mutations may
exist. In this context, one could ask, why have no patients
with mutations in p52 been described yet? Interestingly,
point mutations in the Drosophila homolog of the human
p52, destabilizing the interaction between Dmp52 and
XPB and limiting the stimulation of the ATPase activity of
the latter, give rise to UV sensitivity with melanotic tumors
Mol
in larvae and pupae, and chromosome instability, all char-
acteristics of a DNA repair defect (Fregoso et al., 2007).
The study of such a fly model in association with a full
characterization of the molecular defects associated to
mutations found in humans will be useful to explain the
clinical jumble associated with XP, CS, and TTD patients
mutated in TFIIH genes.
Taken as a whole, our data show that some of the pre-
viously called ‘‘structural’’ subunits of TFIIH (i.e., p52, p44,
p62, and p34) (Tirode et al., 1999) do indeed have crucial
luciferase activity in cell lysates (48 hr posttranfection) normalized with the internal b-galactosidase standard. Results are expressed as relative
luciferase activity. The error bars were calculated on the basis of three independent experiments. Fifty micrograms of total extract was resolved
by SDS-PAGE and western blotted (WB) with mouse anti-human XPB antibody (Coin et al., 2004).
ecular Cell 26, 245–256, April 27, 2007 ª2007 Elsevier Inc. 253
Molecular Cell
Role of XPB and XPD in DNA Repair
functions inside the complex by regulating XPB and XPD
enzymatic functions. Future studies will specially focus
on posttranslational modifications of these regulatory
subunits that may fine-tune TFIIH enzymatic activities,
enabling this factor to participate in a remarkable variety
of processes.
EXPERIMENTAL PROCEDURES
Construction of Plasmids
The cDNAs encoding XPB or p52, p52(1–304), and p52(305–462) were
inserted at the BamHI/EcoRI sites of the FLAG-tagged pSK278 vector
(BD Biosciences) in fusion with the FLAG peptide (MTKDDDDKH). The
XPB mutants were obtained by site directed mutagenesis (QuikChange
Site-Directed Mutagenesis Kit, Stratagene). The resulting vectors were
recombined with baculovirus DNA (BaculoGold DNA, Pharmingen) in
Spodoptera frugiperda 9 (Sf9) cells. For hosT cell reactivation assay,
XPB was inserted into the pcDNA3(+) expression vector (Invitrogen).
Protein Purification
Recombinant wild-type or mutated TFIIH, CAK, and p8/TTDA proteins
were purified as described (Tirode et al., 1999). TFIIH from human cells
was purified using mouse monoclonal anti-p44 antibody linked to pro-
tein A Sepharose. Following washes, the proteins were eluted from the
resin with an excess of the corresponding competitor peptide (Coin
et al., 1999). The FLAG-tagged p52 and XPB proteins were purified
with the anti-FLAG M2 antibody agarose affinity gel (Sigma-Aldrich)
followed by elution with an excess of competitor peptide.
Pull-Down Assay
Wild-type or mutant recombinant XPB from baculovirus-infected Sf9
cell lysates were immunoprecipitated O/N at 4�C in buffer A (50 mM
Tris-HCl [pH 7.9], 20% glycerol, 0.1 mM EDTA, 0.5 mM DTT) contain-
ing KCl (0.2 M) with anti-XPB (1B3) antibody linked to protein A Sephar-
ose beads. Beads were then extensively washed with buffer A (0.4 M
KCl) and re-equilibrated in buffer A (0.2 M KCl). Beads were then incu-
bated with baculovirus-infected Sf9 cell lysates expressing p52 for 2 hr
at 4�C in buffer A (0.2 M KCl), washed extensively with buffer A (0.4 M
KCl), and re-equilibrated in buffer A (0.05 M KCl) before being tested in
western blot or ATPase assay.
DNA Substrates for NER Assays
DNA substrates and dual/single incision assays were performed as
described (Riedl et al., 2003).
Host Cell Reactivation Assay
The pGL3 vector expressing Photinus pyralis (firefly) luciferase was
purchased from Promega and the pCH110 vector expressing the b-
galactosidase from Invitrogen. The pGL3 vector was UV irradiated
(254 nm, 1000 J/m2) at a concentration of 1 mg/ml in 10 mM Tris-
HCl (pH 8.0) and 1 mM EDTA. CHO27-1 cells were transfected in a
6-well plate at a confluence of 95% using Lipofectamine Plus (Invitro-
gen). Each transfection mixture contained 500 ng of pGL3 (UV+/�),
100 ng of pCH110 (nonirradiated), and 10 ng of pcDNAXPB(WT),
(T469A) or (fs740). After 4 hr of incubation, the transfection reagents
were replaced by medium. Cells were lysed after 24 hr to measure lu-
ciferase activity on a microtiter plate luminometer (Dynex). All results
(mean values of at least five measurements) were normalized by calcu-
lating the ratios between luciferase and galactosidase activities.
KMnO4 Footprinting Assay
This assay has been described in Tapias et al. (2004). Briefly, the dam-
aged strand probe was obtained upon AgeI digestion of the Pt-DNA
and radiolabeling at the 30 end in a Klenow reaction, the Pt adduct be-
ing located at 156 bp from the labeled end. The resulting fragment was
purified by the ‘‘crush and soak’’ method after migration in a 5% non-
254 Molecular Cell 26, 245–256, April 27, 2007 ª2007 Elsevier I
denaturating PAGE. Reactions (75 ml) were carried out in 20 mM
HEPES/KOH (pH 7.6), 60 mM KCl, 5 mM MgCl2, 10% glycerol,
1 mM dithiothreitol, 0.3 mM EGTA, 1 mM ATP, 0.4% polyvinyl alcohol,
and 0.4% polyethylene glycol 10,000 buffer containing the labeled cis-
platinated probe (40 fmol) and, when indicated, the NER factors XPC/
HR23b (40 ng) and XPA (25 ng). After incubation at 30�C for 15 min, 3 ml
of 120 mM KMnO4 was added, and oxidation was allowed to proceed
for 3 min at room temperature before reduction by adding 6 ml of 14.6 M
b-mercaptoethanol for 5 min on ice. After organic extraction and eth-
anol precipitation, dried pellets were resuspended in 100 ml of a solu-
tion containing 1 M piperidine, 1 mM EDTA, and 1 mM EGTA and incu-
bated at 90�C for 25 min. Next, samples were ethanol precipitated, and
final pellets were recovered in 10 ml of loading buffer and analyzed in
8% urea-PAGE.
Helicase Assay
The helicase substrate was obtained by annealing 5 ng of an oligonu-
cleotide corresponding to the fragment 6219–6255 of single-stranded
M13mp18 (�) DNA to 1 mg of single-stranded M13mp18 (+). The result-
ing heteroduplex was digested for 1 hr at 37�C with EcoRI (New En-
gland Biolabs) and then extended to 21 and 20 bp, respectively, with
the Klenow fragment (5 units) in the presence of 50 mM dTTP and
7 mCi [a-32P]dATP (3000 Ci/ mmol, Amersham). Helicase assay was
then performed as described (Coin et al., 1998).
ATPase Assay
Protein fractions were incubated for 2 hr at 30�C in the presence of
1 mCi [g-32P]ATP (7000 Ci/mmol, ICN Pharmaceuticals) in a 20 ml reac-
tion volume in 20 mM Tris-HCl (pH 7.9), 4 mM MgCl2, 1 mM DTT,
50 mg/ml BSA, and, when indicated, 120 ng of supercoiled double-
strand DNA (pSK). Reactions were stopped by adding EDTA to
50 mM and SDS to 1% (w/w). The reactions were then diluted
5-fold, spotted onto polyethylenimine (PEI) TLC plates (Merck), run in
0.5 M LiCl/1 M formic acid, and autoradiographed.
Local UV Irradiation
The cells were rinsed with PBS and were covered with an isopore poly-
carbonate filter with pores of 3 mm diameter (Millipore, Bedford, MA).
Cells were then exposed to UV irradiation with a Philips TUV lamp
(predominantly 254 nm) at a dose of 70 J/m2. Subsequently, the filter
was removed, the medium was added back to the cells, and cells
were returned to culture conditions for 30 min.
Fluorescence and Confocal Microscopy
Fibroblasts were grown for 2 days with fluorescent latex beads (Fluo-
resbrite Carboxylate Microspheres, Polysciences), fixed in 3% para-
formaldehyde for 10 min at room temperature, and permeabilized
with PBS/0.5% Triton for 5 min. After washing with PBS-Tween
(0.05%), the slides were incubated for 1 hr with the indicated anti-
bodies. After extensive washing with PBS-Tween, they were incubated
for 1 hr with Cy3-conjugated goat anti-rabbit IgG (Jackson Laborato-
ries) or with anti-mouse Alexa 488 IgG (Jackson Laboratories) diluted
1:400 in PBS-Tween (0.5%). The slides were counterstained for DNA
with DAPI prepared in Vectashield mounting medium (Vector lab). All
images were collected using a Leica Confocal TCS 4D microscope
equipped with both UV laser and an Argon/Kripton laser and standard
filters to allow collection of the data at 488 and 568 nm. The software
TCSTK was used for three-color reconstructions, and figures were
generated using the PLCHTK software.
Antibodies
Mouse monoclonal antibodies toward TFIIH subunits were used as de-
scribed (Marinoni et al., 1997). Anti-FLAG M2 is from SIGMA. Primary
antibodies (the final dilutions are indicated in parentheses) used in fluo-
rescent labeling were rabbit IgG polyclonal anti-XPB (S-19, Santa Cruz
Biotechnology) (1:200), rabbit IgG polyclonal anti-XPA (1:200) (FL-273,
Santa Cruz Biotechnology), and mouse IgG monoclonal anti-CPD
nc.
Molecular Cell
Role of XPB and XPD in DNA Repair
(TDM2) (1:2000) (MBL International Corporation). Secondary anti-
bodies used in this study were Alexa 488 anti-mouse IgG and Cy3-
conjugated goat anti-rabbit IgG.
ACKNOWLEDGMENTS
We thank Mario Zurita for sharing results; Miria Stefanini, Tiziana
Nardo, and Olga Zlobinskaya for fruitful discussions; and Alain Sarasin
for the cell lines. We are grateful to Annabel Larnicol for excellent tech-
nical expertise. We thank Jean-Luc Weickert and Isabelle Kolb for their
invaluable assistance. We are grateful to Renier Velez-Cruz for critical
reading of the manuscript. This study was supported by funds from the
French League against Cancer (CDP 589111) and the French National
Research Agency (NR-05-MRAR-005-01). We also thank the French
Institute for Rare Diseases (number A03098MS). V.O is supported
by the EEC (LSHG-CT-2005-512113).
Received: October 24, 2006
Revised: February 19, 2007
Accepted: March 5, 2007
Published: April 26, 2007
REFERENCES
Bootsma, D., and Hoeijmakers, J.H.J. (1993). DNA repair. Engagement
with transcription. Nature 363, 114–115.
Carreau, M., Eveno, E., Quilliet, X., Chevalier-Lagente, O., Benoit, A.,
Tanganelli, B., Stefanini, M., Vermeulen, W., Hoeijmakers, J.H., Sara-
sin, A., et al. (1995). Development of a new easy complementation
assay for DNA repair deficient human syndromes using cloned repair
genes. Carcinogenesis 16, 1003–1009.
Coin, F., Marinoni, J.C., Rodolfo, C., Fribourg, S., Pedrini, A.M., and
Egly, J.M. (1998). Mutations in the XPD helicase gene result in XP
and TTD phenotypes, preventing interaction between XPD and the
p44 subunit of TFIIH. Nat. Genet. 20, 184–188.
Coin, F., Bergmann, E., Tremeau-Bravard, A., and Egly, J.M. (1999).
Mutations in XPB and XPD helicases found in xeroderma pigmento-
sum patients impair the transcription function of TFIIH. EMBO J. 18,
1357–1366.
Coin, F., Auriol, J., Tapias, A., Clivio, P., Vermeulen, W., and Egly, J.M.
(2004). Phosphorylation of XPB helicase regulates TFIIH nucleotide
excision repair activity. EMBO J. 23, 4835–4846.
Coin, F., De Santis, L.P., Nardo, T., Zlobinskaya, O., Stefanini, M., and
Egly, J.M. (2006). p8/TTD-A as a repair-specific TFIIH subunit. Mol.
Cell 21, 215–226.
Dubaele, S., Proietti De Santis, L., Bienstock, R.J., Keriel, A., Stefanini,
M., Van Houten, B., and Egly, J.M. (2003). Basal transcription defect
discriminates between xeroderma pigmentosum and trichothiodystro-
phy in XPD patients. Mol. Cell 11, 1635–1646.
Evans, E., Moggs, J.G., Hwang, J.R., Egly, J.-M., and Wood, R.D.
(1997). Mechanism of open complex and dual incision formation by
human nucleotide excision repair factors. EMBO J. 16, 6559–6573.
Fan, L., Arvai, A.S., Cooper, P.K., Iwai, S., Hanaoka, F., and Tainer, J.A.
(2006). Conserved XPB core structure and motifs for DNA unwinding:
implications for pathway selection of transcription or excision repair.
Mol. Cell 22, 27–37.
Fregoso, M., Laine, J.P., Aguilar-Fuentes, J., Mocquet, V., Reynaud,
E., Coin, F., Egly, J.M., and Zurita, M. (2007). DNA repair and transcrip-
tional deficiencies caused by mutations in the Drosophila p52 subunit
of TFIIH generate developmental defects and chromosome fragility.
Mol. Cell Biol. Published online March 5, 2007. 10.1128/MCB.
00030-07.
Frit, P., Kwon, K., Coin, F., Auriol, J., Dubaele, S., Salles, B., and Egly,
J.M. (2002). Transcriptional activators stimulate DNA repair. Mol. Cell
10, 1391–1401.
Mole
Gerard, M., Fischer, L., Moncollin, V., Chipoulet, J.M., Chambon, P.,
and Egly, J.M. (1991). Purification and interaction properties of the hu-
man RNA polymerase B(II) general transcription factor BTF2. J. Biol.
Chem. 266, 20940–20945.
Giglia-Mari, G., Coin, F., Ranish, J., Hoogstraten, D., Theil, A., Wijgers,
N., Jaspers, N., Raams, A., Argentini, M., van der Spek, P., et al. (2004).
A new, tenth subunit of TFIIH is responsible for the DNA repair syn-
drome trichothiodystrophy group A. Nat. Genet. 36, 714–719.
Giglia-Mari, G., Miquel, C., Theil, A.F., Mari, P.O., Hoogstraten, D., Ng,
J.M., Dinant, C., Hoeijmakers, J.H., and Vermeulen, W. (2006). Dy-
namic interaction of TTDA with TFIIH is stabilized by nucleotide
excision repair in living cells. PLoS Biol. 4, e156. 10.1371/journal.
pbio.0040156.
Guzder, S.N., Sung, P., Bailly, V., Prakash, L., and Prakash, S. (1994).
RAD25 is a DNA helicase required for DNA repair and RNA polymerase
II transcription. Nature 369, 578–581.
Jawhari, A., Laine, J.P., Dubaele, S., Lamour, V., Poterszman, A., Coin,
F., Moras, D., and Egly, J.M. (2002). p52 mediates XPB function within
the transcription/repair factor TFIIH. J. Biol. Chem. 277, 31761–31767.
Keriel, A., Stary, A., Sarasin, A., Rochette-Egly, C., and Egly, J.M.
(2002). XPD mutations prevent TFIIH-dependent transactivation by
nuclear receptors and phosphorylation of RARalpha. Cell 109, 125–
135.
Lehmann, A.R. (2003). DNA repair-deficient diseases, xeroderma pig-
mentosum, Cockayne syndrome and trichothiodystrophy. Biochimie
85, 1101–1111.
Lin, Y.C., Choi, W.S., and Gralla, J.D. (2005). TFIIH XPB mutants sug-
gest a unified bacterial-like mechanism for promoter opening but not
escape. Nat. Struct. Mol. Biol. 12, 603–607. Published online June 5,
2005. 10.1038/nsmb949.
Ma, L., Westbroek, A., Jochemsen, A.G., Weeda, G., Bosch, A., Boot-
sma, D., Hoeijmakers, J.H., and van der Eb, A.J. (1994). Mutational
analysis of ERCC3, which is involved in DNA repair and transcription
initiation: identification of domains essential for the DNA repair func-
tion. Mol. Cell. Biol. 14, 4126–4134.
Marinoni, J.C., Rossignol, M., and Egly, J.M. (1997). Purification of the
transcription/repair factor TFIIH and evaluation of its associated activ-
ities in vitro. Methods 12, 235–253.
O’Donnovan, A., Davies, A.A., Moggs, J.G., West, S.C., and Wood,
R.D. (1994). XPG endonuclease makes the 30 incision in human DNA
nucleotide excision repair. Nature 371, 432–435.
Oh, K.S., Khan, S.G., Jaspers, N.G., Raams, A., Ueda, T., Lehmann, A.,
Friedmann, P.S., Emmert, S., Gratchev, A., Lachlan, K., et al. (2006).
Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xe-
roderma pigmentosum without and with Cockayne syndrome. Hum.
Mutat. 27, 1092–1103.
Papanikou, E., Karamanou, S., Baud, C., Sianidis, G., Frank, M., and
Economou, A. (2004). Helicase Motif III in SecA is essential for coupling
preprotein binding to translocation ATPase. EMBO Rep. 5, 807–811.
Pause, A., and Sonenberg, N. (1992). Mutational analysis of a DEAD
box RNA helicase: the mammalian translation initiation factor eIF-4A.
EMBO J. 11, 2643–2654.
Riedl, T., Hanaoka, F., and Egly, J.M. (2003). The comings and goings
of nucleotide excision repair factors on damaged DNA. EMBO J. 22,
5293–5303.
Riou, L., Zeng, L., Chevallier-Lagente, O., Stary, A., Nikaido, O., Taieb,
A., Weeda, G., Mezzina, M., and Sarasin, A. (1999). The relative ex-
pression of mutated XPB genes results in xeroderma pigmentosum/
Cockayne’s syndrome or trichothiodystrophy cellular phenotypes.
Hum. Mol. Genet. 8, 1125–1133.
Rossignol, M., Kolb-Cheynel, I., and Egly, J.M. (1997). Substrate spec-
ificity of the cdk-activating kinase (CAK) is altered upon association
with TFIIH. EMBO J. 16, 1628–1637.
cular Cell 26, 245–256, April 27, 2007 ª2007 Elsevier Inc. 255
Molecular Cell
Role of XPB and XPD in DNA Repair
Sijbers, A.M., de Laat, W.L., Ariza, R.R., Biggerstaff, M., Wei, Y.F.,
Moggs, J.G., Carter, K.C., Shell, B.K., Evans, E., de Jong, M.C.,
et al. (1996). Xeroderma pigmentosum group F caused by a defect in
a structure-specific DNA repair endonuclease. Cell 86, 811–822.
Sung, P., Higgins, D., Prakash, L., and Prakash, S. (1988). Mutation of
lysine-48 to arginine in the yeast RAD3 protein abolishes its ATPase
and DNA helicase activities but not the ability to bind ATP. EMBO J.
7, 3263–3269.
Tapias, A., Auriol, J., Forget, D., Enzlin, J.H., Scharer, O.D., Coin, F.,
Coulombe, B., and Egly, J.M. (2004). Ordered conformational changes
in damaged DNA induced by nucleotide excision repair factors. J. Biol.
Chem. 279, 19074–19083.
256 Molecular Cell 26, 245–256, April 27, 2007 ª2007 Elsevier
Tirode, F., Busso, D., Coin, F., and Egly, J.M. (1999). Reconstitution of
the transcription factor TFIIH: assignment of functions for the three
enzymatic subunits, XPB, XPD, and cdk7. Mol. Cell 3, 87–95.
Tuteja, N., and Tuteja, R. (2004). Unraveling DNA helicases. Motif,
structure, mechanism and function. Eur. J. Biochem. 271, 1849–1863.
Volker, M., Mone, M.J., Karmakar, P., van Hoffen, A., Schul, W., Ver-
meulen, W., Hoeijmakers, J.H., van Driel, R., van Zeeland, A.A., and
Mullenders, L.H. (2001). Sequential assembly of the nucleotide exci-
sion repair factors in vivo. Mol. Cell 8, 213–224.
Weeda, G., van Ham, R.C.A., Vermeulen, W., Bootsma, D., van der Eb,
A.J., and Hoeijmakers, J.H.J. (1990). A presumed DNA helicase en-
coded by ERCC-3 is involved in the human repair disorders Xeroderma
Pigmentosum and Cockayne’s syndrome. Cell 62, 777–791.
Inc.